{
  "disease_name": "SLC40A1-related hemochromatosis",
  "orpha_code": "647834",
  "drugs": [
    {
      "name": "(S)-3'-(OH)-desazadesferrithiocin-polyether, magnesium salt",
      "substance_url": "/en/drug/substance/189142?name=647834&mode=orpha&region=&status=all",
      "substance_id": "189142",
      "regulatory_url": "/en/drug/regulatory/208671?name=647834&mode=orpha&region=",
      "regulatory_id": "208671",
      "orpha_substance_code": "ORPHA:647834",
      "details": [
        "(S)-3'-(OH)-desazadesferrithiocin-polyether, magnesium salt(Medicinal product                        - 04/02/2009)Disease(s) concernedORPHA:846 Alpha-thalassemiaORPHA:848 Beta-thalassemiaORPHA:232 Sickle cell anemiaORPHA:647834 SLC40A1-related hemochromatosis",
        "(S)-3'-(OH)-desazadesferrithiocin-polyether, magnesium salt(Medicinal product                        - 04/02/2009)",
        "(Medicinal product                        - 04/02/2009)",
        "Disease(s) concernedORPHA:846 Alpha-thalassemiaORPHA:848 Beta-thalassemiaORPHA:232 Sickle cell anemiaORPHA:647834 SLC40A1-related hemochromatosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/189142?name=647834&mode=orpha&region=&status=all",
          "text": "(S)-3'-(OH)-desazadesferrithiocin-polyether, magnesium salt",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/846",
          "text": "ORPHA:846 Alpha-thalassemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/848",
          "text": "ORPHA:848 Beta-thalassemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/232",
          "text": "ORPHA:232 Sickle cell anemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/647834",
          "text": "ORPHA:647834 SLC40A1-related hemochromatosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/208671?name=647834&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "(S)-3'-(OH)-desazadesferrithiocin-polyether, magnesium salt",
      "substance_url": "/en/drug/substance/189142?name=647834&mode=orpha&region=&status=all",
      "substance_id": "189142",
      "regulatory_url": "/en/drug/regulatory/208572?name=647834&mode=orpha&region=",
      "regulatory_id": "208572",
      "orpha_substance_code": "ORPHA:220489",
      "details": [
        "(S)-3'-(OH)-desazadesferrithiocin-polyether, magnesium salt(Medicinal product                        - 24/07/2009)Disease(s) concernedORPHA:846 Alpha-thalassemiaORPHA:848 Beta-thalassemiaORPHA:232 Sickle cell anemiaORPHA:85 Congenital dyserythropoietic anemiaORPHA:75563 X-linked sideroblastic anemiaORPHA:139507 Dietary iron overload diseaseORPHA:220489 Rare hereditary hemochromatosis",
        "(S)-3'-(OH)-desazadesferrithiocin-polyether, magnesium salt(Medicinal product                        - 24/07/2009)",
        "(Medicinal product                        - 24/07/2009)",
        "Disease(s) concernedORPHA:846 Alpha-thalassemiaORPHA:848 Beta-thalassemiaORPHA:232 Sickle cell anemiaORPHA:85 Congenital dyserythropoietic anemiaORPHA:75563 X-linked sideroblastic anemiaORPHA:139507 Dietary iron overload diseaseORPHA:220489 Rare hereditary hemochromatosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/189142?name=647834&mode=orpha&region=&status=all",
          "text": "(S)-3'-(OH)-desazadesferrithiocin-polyether, magnesium salt",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/846",
          "text": "ORPHA:846 Alpha-thalassemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/848",
          "text": "ORPHA:848 Beta-thalassemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/232",
          "text": "ORPHA:232 Sickle cell anemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/85",
          "text": "ORPHA:85 Congenital dyserythropoietic anemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/75563",
          "text": "ORPHA:75563 X-linked sideroblastic anemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/139507",
          "text": "ORPHA:139507 Dietary iron overload disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/220489",
          "text": "ORPHA:220489 Rare hereditary hemochromatosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/208572?name=647834&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "ORPHA:220489 Rare hereditary hemochromatosis\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "4,5-dihydro-2-(2,4-dihydroxyphenyl)-4-methylthiazole-4(S)-carboxylic acid",
      "substance_url": "/en/drug/substance/82350?name=647834&mode=orpha&region=&status=all",
      "substance_id": "82350",
      "regulatory_url": "/en/drug/regulatory/133860?name=647834&mode=orpha&region=",
      "regulatory_id": "133860",
      "orpha_substance_code": "ORPHA:220489",
      "details": [
        "4,5-dihydro-2-(2,4-dihydroxyphenyl)-4-methylthiazole-4(S)-carboxylic acid(Medicinal product                        - 12/12/2003)Disease(s) concernedORPHA:846 Alpha-thalassemiaORPHA:848 Beta-thalassemiaORPHA:232 Sickle cell anemiaORPHA:53693 GRACILE syndromeORPHA:220489 Rare hereditary hemochromatosis",
        "4,5-dihydro-2-(2,4-dihydroxyphenyl)-4-methylthiazole-4(S)-carboxylic acid(Medicinal product                        - 12/12/2003)",
        "(Medicinal product                        - 12/12/2003)",
        "Disease(s) concernedORPHA:846 Alpha-thalassemiaORPHA:848 Beta-thalassemiaORPHA:232 Sickle cell anemiaORPHA:53693 GRACILE syndromeORPHA:220489 Rare hereditary hemochromatosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/82350?name=647834&mode=orpha&region=&status=all",
          "text": "4,5-dihydro-2-(2,4-dihydroxyphenyl)-4-methylthiazole-4(S)-carboxylic acid",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/846",
          "text": "ORPHA:846 Alpha-thalassemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/848",
          "text": "ORPHA:848 Beta-thalassemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/232",
          "text": "ORPHA:232 Sickle cell anemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/53693",
          "text": "ORPHA:53693 GRACILE syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/220489",
          "text": "ORPHA:220489 Rare hereditary hemochromatosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/133860?name=647834&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "ORPHA:220489 Rare hereditary hemochromatosis\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Deferasirox",
      "substance_url": "/en/drug/substance/69829?name=647834&mode=orpha&region=&status=all",
      "substance_id": "69829",
      "regulatory_url": "/en/drug/regulatory/133773?name=647834&mode=orpha&region=",
      "regulatory_id": "133773",
      "orpha_substance_code": "ORPHA:220489",
      "details": [
        "Deferasirox(Medicinal product                        - 13/03/2002)Disease(s) concernedORPHA:846 Alpha-thalassemiaORPHA:848 Beta-thalassemiaORPHA:232 Sickle cell anemiaORPHA:220489 Rare hereditary hemochromatosis",
        "Deferasirox(Medicinal product                        - 13/03/2002)",
        "(Medicinal product                        - 13/03/2002)",
        "Disease(s) concernedORPHA:846 Alpha-thalassemiaORPHA:848 Beta-thalassemiaORPHA:232 Sickle cell anemiaORPHA:220489 Rare hereditary hemochromatosis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/69829?name=647834&mode=orpha&region=&status=all",
          "text": "Deferasirox",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/846",
          "text": "ORPHA:846 Alpha-thalassemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/848",
          "text": "ORPHA:848 Beta-thalassemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/232",
          "text": "ORPHA:232 Sickle cell anemia",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/220489",
          "text": "ORPHA:220489 Rare hereditary hemochromatosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/133773?name=647834&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Burixafor",
      "substance_url": "/en/drug/substance/689505?name=647834&mode=orpha&region=&status=all",
      "substance_id": "689505",
      "regulatory_url": "/en/drug/regulatory/689915?name=647834&mode=orpha&region=",
      "regulatory_id": "689915",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Burixafor(Medicinal product                        - 22/10/2024)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Burixafor(Medicinal product                        - 22/10/2024)",
        "(Medicinal product                        - 22/10/2024)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/689505?name=647834&mode=orpha&region=&status=all",
          "text": "Burixafor",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/689915?name=647834&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Treosulfan",
      "substance_url": "/en/drug/substance/90799?name=647834&mode=orpha&region=&status=all",
      "substance_id": "90799",
      "regulatory_url": "/en/drug/regulatory/136690?name=647834&mode=orpha&region=",
      "regulatory_id": "136690",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Treosulfan(Medicinal product                        - 08/04/2015)Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Treosulfan(Medicinal product                        - 08/04/2015)",
        "(Medicinal product                        - 08/04/2015)",
        "Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/90799?name=647834&mode=orpha&region=&status=all",
          "text": "Treosulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/213500",
          "text": "ORPHA:213500 Rare ovarian cancer",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/136690?name=647834&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "busulfan",
      "substance_url": "/en/drug/substance/46335?name=647834&mode=orpha&region=&status=all",
      "substance_id": "46335",
      "regulatory_url": "/en/drug/regulatory/131973?name=647834&mode=orpha&region=",
      "regulatory_id": "131973",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "busulfan(Medicinal product                        - 21/04/1994)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "busulfan(Medicinal product                        - 21/04/1994)",
        "(Medicinal product                        - 21/04/1994)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/46335?name=647834&mode=orpha&region=&status=all",
          "text": "busulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131973?name=647834&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:05:00.943031",
  "run_number": 1,
  "total_drugs_found": 7,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=SLC40A1-related+hemochromatosis&orphaCode=647834&name=647834&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "SLC40A1-related hemochromatosis",
    "orphaCode": "647834",
    "name": "647834",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}